Answers are grounded in this paper and cite their sources.
Background.Cardiovascular risk stratification is crucial in patients with end-stage liver disease (ESLD) yet the optimal non-invasive strategy remains debated.Our study aimed to assess the prognostic value of coronary computed tomography angiography (CTA) and coronary artery calcium (CAC) in patients undergoing orthotopic liver transplantation (LT).Methods.Patients with ESLD scheduled for LT referred to coronary CTA and coronary artery calcium score (CAC) were included.Primary endpoint was all-cause mortality, secondary endpoint myocardial infarction (MI).Results.458 patients for pre-LT risk stratification were enrolled with 270 LT recipients (79.3% male; mean age 618.5 years) finally being included.Mean follow-up was 7.53.1 years, range 2-13.Among 248 patients undergoing CTA, the majority (n=173, 69.8%) had CAD by CTA, (CADRADS 1-5), and n=75 (30.2%) had no coronary artery disease (CAD).Stenosis severity was minimal-to-mild (<50%) in 112 (45.1%), intermediate (50-70%) in 44 (17.7%), and severe (>70%) in 17 (6.5%) of patients.All-cause mortality rate was 46 (17.0%) (n=3 cardiovascular).Stenosis severity (CAD-RADS) was associated with mortality (Kaplan-Meier analysis, p<0.001).On multivariate Cox regression, total plaque burden were associated with all-cause mortality (HR 1.1, p=0.034; 95% CI 0.649-0.983and HR 1.1, p=0.029; 95% CI 1.0-1.6),while CAC score was not.Six acute myocardial infarctions (MI) (3 STEMI, 3 NSTEMI) occurred, none of them (0%) in patients with CAD-RADS 0-1, and 100% CAD-RADS 2-4. Conclusion.Coronary CTA is a valuable tool for pre-LT CV risk assessment.Patients with no or minimal CAD on CTA have an excellent prognosis regarding survival.
No takes yet. Share an insight, caveat, or question.
Lacaita et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: